Incyte Corp. (INCY)
105.39
+2.16
(+2.09%)
USD |
NASDAQ |
Jun 10, 16:00
105.38
-0.01
(-0.01%)
After-Hours: 04:36
Incyte Profit Margin (Quarterly) : 23.83% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 23.83% |
| December 31, 2025 | 19.86% |
| September 30, 2025 | 31.05% |
| June 30, 2025 | 33.32% |
| March 31, 2025 | 15.03% |
| December 31, 2024 | 17.07% |
| September 30, 2024 | 9.36% |
| June 30, 2024 | -42.60% |
| March 31, 2024 | 19.25% |
| December 31, 2023 | 19.84% |
| September 30, 2023 | 18.64% |
| June 30, 2023 | 21.32% |
| March 31, 2023 | 2.68% |
| December 31, 2022 | 3.07% |
| September 30, 2022 | 13.70% |
| June 30, 2022 | 17.71% |
| March 31, 2022 | 5.18% |
| December 31, 2021 | 65.35% |
| September 30, 2021 | 22.35% |
| June 30, 2021 | 21.18% |
| March 31, 2021 | 8.85% |
| December 31, 2020 | 18.98% |
| September 30, 2020 | -2.45% |
| June 30, 2020 | 42.19% |
| March 31, 2020 | -126.8% |
| Date | Value |
|---|---|
| December 31, 2019 | 19.16% |
| September 30, 2019 | 23.26% |
| June 30, 2019 | 19.87% |
| March 31, 2019 | 20.55% |
| December 31, 2018 | 13.07% |
| September 30, 2018 | 6.49% |
| June 30, 2018 | 10.05% |
| March 31, 2018 | -10.76% |
| December 31, 2017 | -33.69% |
| September 30, 2017 | 9.45% |
| June 30, 2017 | -3.82% |
| March 31, 2017 | -48.71% |
| December 31, 2016 | 2.72% |
| September 30, 2016 | 13.69% |
| June 30, 2016 | 13.98% |
| March 31, 2016 | 9.13% |
| December 31, 2015 | 22.62% |
| September 30, 2015 | -21.10% |
| June 30, 2015 | 5.70% |
| March 31, 2015 | -11.53% |
| December 31, 2014 | -29.80% |
| September 30, 2014 | 29.92% |
| June 30, 2014 | -37.03% |
| March 31, 2014 | -37.82% |
| December 31, 2013 | -44.16% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 17.65% |
| BioMarin Pharmaceutical, Inc. | 13.55% |
| Vertex Pharmaceuticals, Inc. | 34.24% |
| Mirum Pharmaceuticals, Inc. | -494.2% |
| Biogen, Inc. | 13.29% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 30.75% |
| Return on Assets | 22.22% |
| Return on Invested Capital | 30.46% |
| Gross Profit Margin (Quarterly) | 90.46% |
| Operating Margin (Quarterly) | 25.47% |
| Return on Net Operating Assets | 69.14% |